9:22 AM
Leo Group India
| ||
| Avraham Pharmaceuticals Announces Commencement of a Phase 2 Study of ... MarketWatch (press release) YAVNE, Israel, May 17, 2012 (BUSINESS WIRE) -- --Yaacov Michlin appointed Chairman of the Board and Dr. Yona Geffen appointed Chief Executive Officer Avraham Pharmaceuticals Ltd. announced today the commencement of a Phase 2 clinical trial to evaluate ... See all stories on this topic » | ||
| Auxilium Pharmaceuticals, Inc. and FCB I LLC Announce the Issuance of ... MarketWatch (press release) The newly issued patent, which claims certain pharmaceutical compositions comprising testosterone, is expected to expire in April 2023. Auxilium has also submitted the patent for listing in the Approved Drug Products with Therapeutic Equivalence ... See all stories on this topic » | ||
| Spectrum Pharmaceuticals Commences Phase 2 Study of ZEVALIN(R) in Combination ... MarketWatch (press release) Spectrum Pharmaceuticals (nasdaqgs:SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced the initiation of a Phase 2 study evaluating ZEVALIN(R) ... See all stories on this topic » | ||
| Sagent Pharmaceuticals Announces Launch of Irinotecan Hydrochloride Injection ... MarketWatch (press release) SCHAUMBURG, Ill., May 17, 2012 (GlobeNewswire via COMTEX) -- Sagent Pharmaceuticals, Inc. (NASDAQ:SGNT) today announced the launch of Irinotecan Injection, the generic form of the chemotherapy drug Camptosar(R), in two latex free, preservative free ... See all stories on this topic » | ||
| New Competitive Arena Emerges for Pharmaceutical Companies in Healthcare's ... MarketWatch (press release) NEW YORK, May 17, 2012 /PRNewswire via COMTEX/ -- Pharmaceutical companies that are first to meet healthcare's new expectations of value could have an advantage in the competition for market share and brand differentiation, according to a report ... See all stories on this topic » | ||
| DEA suspends Ohio pharmaceutical distributor for two years InjuryBoard.com Pharmaceutical drug and medical product provider Cardinal Health's website boasts, "Through every link in the chain of care, pharmacies, hospitals and clinics rely on us to improve quality, safety and productivity." Today, those healthcare providers ... See all stories on this topic » | ||
| Optimer Pharmaceuticals Inc. Stock Downgraded (OPTR) TheStreet.com By TheStreet Wire 05/17/12 - 05:00 AM EDT NEW YORK (TheStreet) -- Optimer Pharmaceuticals (Nasdaq:OPTR) has been downgraded by TheStreet Ratings from hold to sell. The company's weaknesses can be seen in multiple areas, such as its deteriorating net ... See all stories on this topic » | ||
| ||
| Research and Markets: Active Pharmaceutical Ingredients in Italy SunHerald.com This report supplies information on the Active Pharmaceutical Ingredients Italian market and its competitors: market trends, SWOT and key success factors analysis, major companies performance indicators (total turnover, sector specific turnover, ... See all stories on this topic » | ||
| West Pharmaceutical Services Stays On Its Margin Hot Streak msnbc.com The more West Pharmaceutical Services keeps of each buck it earns in revenue, the more money it has to invest in growth, fund new strategic plans, or (gasp!) distribute to shareholders. Healthy margins often separate pretenders from the best stocks in ... See all stories on this topic » |
Tip: Use site restrict in your query to search within a site (site:nytimes.com or site:.edu). Learn more.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment